ML20135B036

Forwards Request for Addl Info Re Util 850701 Request for Exemption from 10CFR20 Respiratory Protection Iodine Filter Requirement.Response Requested within 60 Days of Ltr Receipt

ML20135B036
Person / Time
Site:	Wolf Creek
Issue date:	09/05/1985
From:	Youngblood B Office of Nuclear Reactor Regulation
To:	Koester G KANSAS GAS & ELECTRIC CO.
References
TAC-59366, NUDOCS 8509100381
Download: ML20135B036 (5)

Text

.

Docket No.: 50-482 SEP 0 51985 Mr. Glenn L. Koester Vice President - Nuclear Kansas Gas and Electric Company 201 North Market Street Post Office Box 208 Wichita, Kansas 67201

Subject:

Request for Additional Information Regarding a 10 CFR 20 Respiratory Protection Iodine Filter Exemption Requests The NRC staff is continuing its rev'ew of KG&E's 10 CFR 20 Respiratory Protection Iodine Filter Exemption request submitted by letter dated July 1, 1985. The in-formation requested in the enclosure is necessary to permit the staff to complete its review.

Please provide the requested information with 60 days of your receipt of this letter.

Sincerely, B. J. Youngblood, Chief Licensing Branch No. 1 Division of Licensing

Enclosure:

As stated cc: See next page DISTRIBUTION:

Docket File e NRC PDR Local PDR PRC System NSIC LBf1 R/F MRushbrook P0'Connor OELD 1 ACRS (16) l JPartlow l

' l BGrimes EJordan i LB#1/DL 9 LBil/DL LB P0'Connor/mac TAlexion we lhlY blood q / 5 /85 g /( /85 y/ /85

^

0509100381 850905 PDR P ADOCK 05000482 PDR '

J

Mr. Glenn L. Koester Wolf Creek Generating Station Kansas Gas and Electric Company -

Unit No. 1 I cc:

Mr. Nicholas A. Petrick Ms. Wanda Christy Executive Director, SNUPPS 515 N. Ist Street 5 Choke Cherry Road Burlington, Kansas 66839 Rockville, Maryland 20850 C. Edward Peterson, Esq.

Jay Silberg, Esq. Legal Division Shaw, Pittman, Potts & Trowbridge Kansas Corporation Commission 1800 M Street, NW State Office Building, Fourth Floor Washington, D.C. 20036 Topeka, Kansas 66612 Mr. Donald T. McPhee John M. Simpson, Esq.

Vice President - Production Attorney for Intervenors Kansas City Power & Light Company 4350 Johnson Drive, Suite 120 1330 Baltimore Avenue Shawnee Mission, Kansas 66205 Kansas City, Missouri 64141 Regional Administrator, Region IV Ms. Mary Ellen Salva U.S. Nuclear Regulatory Commission Route 1, Box 56 Office of Executive Director Burlington, Kansas 66839 for Operations 611 Ryan Plaza Drive, Suite 1000 A. Scott Cauger Arlington, Texas 76011 Attistant General Counsel Public Service Comission Mr. Allan Mee P. O. Box 360 Project Coordinator Jefferson City, Missouri 65101 Kansas Electric Power Cooperative,Inc.

P. O. Box 4877 Resident Inspector / Wolf Creek NPS Gage Center Station c/o U.S. Nuclear Regulatory Comission Topeka, Kansas 66604 P. O. Box 311 Burlington, Kansas 66893 Regional Administrator, Region III U.S. Nuclear Regulatory Comission Mr. Robert M. Fillmore 799 Roosevelt Road ,

State Coporation Comission Glen Ellyn, Illinois 60137 State of Kansas Fourth Floor, State Office Building Brian P. Cassidy, Regional Counsel Topeka, Kansas 66612 Federal Emergency Management Agency Region I J. W. McCormack P0CH Boston, Massachusetts 02109 l

l

I Kansas Gas and Electric Company Wolf Creek Generating Station

. Unit No. 1 1

cc: l Terri Sculley, Director '

Special Projects Division Kansas Corporation Commission State Office Building, Fourth Floor Topeka, Kansas 66612 Mr. Gerald Allen Public Health Physicist Bureau of Air Quality & Radiation Control Division of Environment Kansas Department of Health and Environment Forbes Field Building 321 Topeka, Kansas 66620 Senior Resi, dent Inspector / Wolf Creek NPS c/o U.S. Nuclear Regulatory Commission P. O. Box 311 Burlington, Kansas 66839 4

i

ENCLOSURE WOLF CREEK GENERATING STATION 1

j REQUEST FOR ADDITIONAL INFORMATION IODINE FILTER EXEMPTION

1. Your submittal of July 1,1985 indicates that the exemption can result in potential person-reni reductions over the life of the plant. Briefly discuss particular tasks you have identified which could result in such dose savings and/or provide examples of relevant industry experience in this area (e.g. Farley 1 & 2. San Onofre).

2. Discuss facility programs intended to preclude high radiciodine levels.

Include a general description of fuel quality assurance and quality control, as well as routinely practiced operational techniques, engineering controls, and procedures used to prevent use of faulty fuel, prevent fuel damInge, and minimize the radiological impact of potential fuel defects (e.g. coolant purification, chemistry control,

sampling, degasification, planned decay, fuel sipping and replacement).

3. Provide a commitment that training programs will be modified and training will be conducted to instruct sorbent canister users and health physics personnel in the proper field use of these canisters, as well l as the limitations and restrictions regarding their use. Identify the,,

specific procedures related to such training and to use and control .-

of these canisters.

5

4. Describe how vendor and facility quality assurance ,and quality control will be verified for the GPEt-I canister. This should include a discussion of how the licensee will verify and accept MSA's QA procedures for the GPEt-I canister (i.e. Mil Std 414), and how on-site quality control'.

willbemaintainedtoassureidentification,useandstoragieofQA'd GPEt-I canisters. .

5. Provide a comitment that on-site storage in a cool, dry environment will meet QA Class A Storage as outlined in ANSI N45.2.2, or an equivalent inspectable storage criteria. Note that canister storage t -

in field use/ issue areas need not meet such criteria if such storage is temporary and related to field issue and use.

I

.- . . - . ,, - - . - - - - - , - - - - , , . - . .-- -,,-.~=

6. Provide a comitment to verify the effectiveness of GMR-I canister use, to include the following , or equivalent, controls:

a. weekly whole body counts for individuals using the GMR-J canister for radiciodine protection;

b. for individuals who exceed 10 MPC hours, a whole body count will be required prior to the individual's next entry into a radio-iodine atmosphere;

c. establish an uptake level beyond which further entry into a radioiodine atmosphere would be restricted, pending health physics evaluation (e.g. at 70 nCi);

d. establish a data base of survey data and whole body counts to be

~

used to evaluate the effectiveness of the program.

7. Provide additional details regarding the limitations and controls for~

use of the GMR-I canisters as follows:

a. Identify those organic vapors of concern at Wolf Creek (e.g. freons, alcohols, carbon tetrachloride, paint fumes, EDTA, etc.) where GMR-I canisters are to be used or stored.

b. Outline the methods and procedures to be used to preclude the presence of organic vaports in canister use areas, and briefly discuss detection and sampling methods to be used, where these are feasible. Outline the sampling program for radiciodines

~

and what measures will be taken to establish baseline data for organics which are not readily sampled or dgtected,

c. Discuss the frequency and conditions for determination of temperature and dew point / relative humidity during canister use.

(120'F is acceptable if dew point does not exceed'107*).

8. Verify that facepiece protection factors will have been determined by fit test to be greater than 100 PF capability.

9. Identify existing requirements (related to Q471.7), such as technical specifications for main HEPA filter banks, which provide measures of l control for the environments where GMR-I canisters will be used, and l briefly indicate how they contribute to control of use and conditions.

l l

l I